Kimberly-Clark has agreed to buy Tylenol maker Kenvue for about $48.7 billion, sending the drug manufacturer’s shares soaring 18% in premarket trading Monday. The deal will create a new consumer health giant, bringing Kenvue under the wing of the maker of Kleenex tissues and Huggies diapers. Kenvue CEO Kirk Perry said it would allow the company to “innovate even faster.” Kenvue has been under pressure in recent weeks amid attacks by the Trump administration on Tylenol, its most recognizable product. Pres ...